• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies

    Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics

    NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidisciplinary research questions, generate insights, and integrate that information back into their existing Oracle Health and Life Sciences applications. As a result, life sciences organizations can more accurately identify market needs, assess commercial viability, and optimize therapeutic launch strategies. This innovation is yet another step in Oracle's vision to bridge the gap between clinical research and clinical care.

    (PRNewsfoto/Oracle)

    "Oracle continues to deliver game-changing products that modernize and enhance clinical research and tighten the connection between bench and bedside," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "With Oracle Analytics Intelligence for Life Sciences, we are breaking down the silos that have stifled innovation in the industry and are delivering the tools and intelligence needed to help advance insights and therapies with speed and precision."

    Supported by a wide variety of real-world data sources, such as CancerMPact and multiomics, the platform delivers actionable insights out of the box with pre-built curated datasets, data pipelines, adaptable models, and analytics for determining patient experience, safety monitoring, therapy effectiveness, and brand measurement. Oracle Analytics Intelligence for Life Sciences customers who use the Oracle Learning Health Network will also have continuously updated anonymized Oracle Real World Data (ORWD) available in their analytics environment, which broadens their access to even more information.

    Oracle Analytics Intelligence for Life Sciences is powered by Oracle Health Data Intelligence (HDI). Built on the security and high performance of Oracle Cloud Infrastructure (OCI), Oracle Health Data Intelligence integrates, secures, and analyzes data from a broad range of sources including electronic health records (EHR), enterprise applications, insurance claims, and demographic records, to provide a more comprehensive view of individual patients and overall population health.

    This proven, EHR-agnostic platform is a continuously learning ecosystem that powers provider applications to support intelligent clinical decision-making, care coordination, and value-based care delivery. With Oracle Analytics Intelligence for Life Sciences, Oracle is now extending this platform to enable clinical research and insight generation, which feeds back into the HDI ecosystem in a continuous learning loop.

    The platform was developed in coordination with Oracle's globally renowned Research Services division, merging cutting-edge technology with deep domain expertise. This collaboration brings together top life sciences experts, including the oncology researchers behind CancerMPact, to deliver a groundbreaking platform that advances insights and therapies with unmatched speed and precision.

    For more information about Oracle Analytics Intelligence for Life Sciences visit: https://www.oracle.com/life-sciences/

    To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-launches-ai-powered-oracle-analytics-intelligence-for-life-sciences-302291197.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What is the recent product launched by Oracle for life sciences?

      Oracle has launched the Oracle Analytics Intelligence for Life Sciences, an AI-powered platform designed to unite disparate data sets and accelerate insight generation for life sciences organizations.

    • What types of data sources does the Oracle Analytics Intelligence for Life Sciences utilize?

      The new platform integrates data from various sources, including electronic health records, insurance claims, and demographic records, to provide comprehensive insights on patient experiences and therapy effectiveness.

    • How does Oracle Analytics Intelligence for Life Sciences intend to impact therapeutic launch strategies?

      This platform aims to bridge the gap between clinical research and clinical care, allowing organizations to identify market needs, assess the commercial viability of treatments, and optimize therapeutic launch strategies.

    • What functionalities does the Oracle Analytics Intelligence platform offer to its users?

      The platform supports multidisciplinary research questions and continuously updates insights using real-world data to improve decision-making and patient care outcomes.

    • What is Oracle's broader vision with the introduction of the Analytics Intelligence for Life Sciences?

      The launch is part of Oracle's strategy to modernize clinical research and tightens the connection between research and actual patient care through advanced analytics and data integration.

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    3/11/2026$210.00Neutral → Overweight
    Analyst
    3/11/2026$205.00 → $200.00Outperform
    BMO Capital Markets
    3/11/2026$185.00 → $210.00Outperform
    Oppenheimer
    2/25/2026$185.00Perform → Outperform
    Oppenheimer
    2/9/2026Buy → Hold
    Melius
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    1/12/2026$240.00Buy
    Goldman
    More analyst ratings

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Magouyrk Clayton M. sold $1,552,318 worth of shares (10,000 units at $155.23), decreasing direct ownership by 7% to 134,030 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/11/26 4:42:45 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by EVP, Chief Legal Officer Levey Stuart

    4 - ORACLE CORP (0001341439) (Issuer)

    1/26/26 5:15:41 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    EVP, Principal Financial Offcr Kehring Douglas A sold $6,821,150 worth of shares (35,000 units at $194.89), decreasing direct ownership by 51% to 33,638 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    1/16/26 4:15:34 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles

    NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- MiningNewsWire Editorial Coverage: Rare earth metallization sits deep in the industrial stack, but it is one of the steps that determines whether advanced manufacturing can actually function at scale. China's dominance over rare earth refining, metallization and magnet production has left automakers, electronics manufacturers, robotics developers, defense contractors and data-center-adjacent industrial supply chains exposed to a single concentrated source. That exposure helps explain why companies such as REalloys (NASDAQ:ALOY) (MNW Profile News) are drawing attention – The company is working to rebuild a North American mine-to-magnet platform t

    3/18/26 9:00:00 AM ET
    $ALOY
    $AMD
    $IBM
    Semiconductors
    Technology
    Computer Manufacturing
    Computer Software: Programming Data Processing

    New Oracle AI Smart Assistant Capabilities Help Restaurants Streamline Operations and Support

    Oracle Simphony POS provides management and staff real-time brand responses to common technical questions to run more efficientlyCHICAGO, March 18, 2026 /PRNewswire/ -- Oracle Restaurants Summit -- Oracle today announced new Smart Assistant capabilities in Oracle Simphony Cloud Point of Sale (POS). The embedded, generative AI assistant empowers restaurant teams with self-service suggestions resolve common technical and operational issues more quickly. With this real-time intelligence personalized to the guidelines of each brand, restaurants can boost efficiency, fix issues faster, and reduce the need for external support calls and intervention.

    3/18/26 7:45:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Fans Score with New Oracle Suite Service and Mobile Ordering Capabilities

    Oracle Simphony Cloud eases ordering for fans, while streamlining operations and fulfillment for venue operators CHICAGO, March 18, 2026 /PRNewswire/ -- Oracle Restaurants Summit -- Elevating concession ordering from jeers to cheers, Oracle has expanded its Oracle Simphony Cloud Point of Sale (POS) roster with new Oracle Restaurant Suites Management, and Oracle Mobile Order and Pay capabilities. With these offerings venues can deliver exceptional fan experiences all on one, unified cloud platform. A sweeter suite experienceOracle Restaurant Suite Management streamlines premium s

    3/18/26 7:45:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    SEC Filings

    View All

    SEC Form 10-Q filed by Oracle Corporation

    10-Q - ORACLE CORP (0001341439) (Filer)

    3/11/26 6:38:49 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - ORACLE CORP (0001341439) (Filer)

    3/10/26 4:12:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form CERT filed by Oracle Corporation

    CERT - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:24:57 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oracle upgraded by Analyst with a new price target

    Analyst upgraded Oracle from Neutral to Overweight and set a new price target of $210.00

    3/11/26 8:29:46 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $200.00 from $205.00 previously

    3/11/26 8:12:23 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oppenheimer reiterated coverage on Oracle with a new price target

    Oppenheimer reiterated coverage of Oracle with a rating of Outperform and set a new price target of $210.00 from $185.00 previously

    3/11/26 7:58:25 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/14/25 4:41:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    View All

    Health Systems Simplify Secure Data Exchange with Oracle Health

    New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr

    10/9/25 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SoftBank Group to Acquire Ampere Computing

    SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

    3/19/25 7:30:00 PM ET
    $CG
    $ORCL
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Financials

    Live finance-specific insights

    View All

    Oracle Announces Fiscal Year 2026 Third Quarter Financial Results

    Q3 Remaining Performance Obligations $553 billion, up 325% year-over-year in USDQ3 GAAP Earnings per Share up 24% to $1.27, Non-GAAP Earnings per Share up 21% to $1.79Q3 Total Revenue $17.2 billion, up 22% in USD and up 18% in constant currencyQ3 Cloud Revenue (IaaS plus SaaS) $8.9 billion, up 44% in USD and up 41% in constant currency Q3 Cloud Infrastructure Revenue (IaaS) $4.9 billion, up 84% in USD and up 81% in constant currencyQ3 Oracle Cloud Database (IaaS) Revenue up 35%, Multicloud Database Revenue up 531% in USDQ3 Cloud Application (SaaS) Revenue $4.0 billion, up 13% in USD and up 11% in constant currencyQ3 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 17% in USD and up 14% in co

    3/10/26 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its Third Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on March 10, 2026, After the Close of the MarketAUSTIN, Texas, March 3, 2026 /PRNewswire/ -- Oracle Corporation today announced that its third quarter fiscal year 2026 results will be released on Tuesday, March 10th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About OracleOracle offers integrated suites of applications plus secure, autonomous infr

    3/3/26 4:00:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Announces Fiscal Year 2026 Second Quarter Financial Results

    Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI

    12/10/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/23 4:31:02 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/22 8:28:11 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology